Back to list

Collagenase: A Protease That "Unravels" the Collagen Triple Helix

Published on November 8, 2026

Collagenase: A Protease That "Unravels" the Collagen Triple Helix

figure1. Overview of collagenase degrading the collagen triple helix



1. Industrial Landing and Process Pain Points

1.1 Why Collagen Is "Hard to Degrade"

Collagen is an extremely abundant structural protein in animal tissue; its core is a superhelix formed by three α chains. This dense, ordered helix is not friendly to general proteases, which usually can only nibble at the edges and struggle to enter the helix. What can truly unravel it under physiological conditions is collagenase.

In plain terms, collagen is like three strands of rope twisted tightly together. Most proteases can only rub off fibers at the end; collagenase can work between the strands, loosening and cutting the helix section by section.

1.2 Three Main Application Scenarios

Collagenase value is concentrated in three scenarios. The first is chronic wound debridement: necrotic tissue adheres to new granulation tissue via a collagen network, and clostridial collagenase ointment can selectively remove necrotic tissue without harming healthy granulation and epithelium. The second is fibrotic disease: Dupuytren's contracture and Peyronie's disease involve dense collagen cords or plaques, and intralesional collagenase injection can relax contractures and reduce curvature. The third is tissue dissociation in bioprocessing: pancreatic islet isolation and primary cell preparation rely on collagenase to loosen tissue into cell clusters or single cells.

1.3 Process Pain Points

In practice, pain points cluster around several issues: large batch activity variation leading to unstable dissociation yield; collagenase carrying other protease activity that may harm target cells; over-digestion causing cell damage while under-digestion lowers yield; and non-comparability across different sources and grades. These all point to one need: a collagenase with controlled activity, clear specificity and stable batch behavior.


2. Technical Evolution

Early collagenase often came from crude clostridial cultures, with impurities, large batch variation and high endotoxin. Subsequent directions were purification and recombinant production: expressing single or mixed collagenases recombinantly to improve purity and batch-to-batch activity consistency. Recombinant mixed systems (e.g., low-dose collagenase-protease blends) showed better islet recovery and transplant outcomes in islet isolation. The evolution line runs from "crude and mixed" to "refined, controlled and scalable."


3. Molecular Mechanism


Mechanism of collagenase cleaving the X-Gly bond.

 figure2. Mechanism of collagenase cleaving the X-Gly bond

3.1 Cleavage Site: X–Gly Peptide Bond

Clostridial collagenase acts on the X–Gly peptide bond within the triple helix, placing glycine at the scissile site, with a preference for glycine at P3 and P1'. This site selection lets collagenase systematically dismantle the helix rather than take random bites.

3.2 Synergy of Type I and Type II Collagenases

Clostridial collagenase is a family with multiple members. Type I (e.g., AUX-I, ColG) and type II (e.g., AUX-II, ColH) are complementary in strategy: type II can work inside the triple helix. Together they degrade dense collagen more thoroughly, which is the structural basis for clinical preference for mixed-type collagenase over a single type.

3.3 Metal Dependence

Collagenase is a metalloprotease. Zinc sits in the active site and drives catalysis; calcium stabilizes conformation and participates in substrate binding. Systems containing chelators such as EDTA markedly lower activity, so metal ions must be considered in selection and formulation.


4. Critical Control Points and Substrate Adaptation

4.1 pH Window

Collagenase has an optimal pH of 6–8, with activity falling markedly outside this range. Both debridement ointments and injectable formulations must maintain an appropriate pH to preserve activity and stability.

4.2 Temperature, Ions and Inhibitors

Reaction temperature is near physiological ranges, generally used in vivo or at 37°C for tissue dissociation; calcium is important for stability and activity, zinc for catalysis. Systems containing metal chelators or strong oxidants should be avoided; if protease inhibitors are present, determine whether they also inhibit collagenase itself.

4.3 Substrate Adaptation Difficulty

Different tissues differ in collagen type and density, so dissociation difficulty varies. Islet, skin, tendon and cartilage each have distinct collagen compositions and crosslinking, and enzyme dosage, incubation time and enzyme-type ratios all need targeted adjustment. Blindly copying a protocol from one tissue often leads to batch failure.


5. Technical Route Comparison

5.1 Natural Extraction vs Recombinant Expression

Natural clostridial collagenase comes from fermentation culture, is cheaper, but shows obvious batch variation and may carry other clostridial proteases and endotoxin. Recombinant expression markedly improves purity and batch consistency and reduces off-target protease activity, making it the first choice for clinical and high-demand bioprocessing.

5.2 Single Type vs Mixed Type

A single collagenase type has relatively clear specificity but limited efficiency on dense collagen; mixing types I and II covers cleavage at both the surface and interior of the helix, giving more thorough degradation. Clinical and islet-isolation scenarios lean toward mixed type.

5.3 Different Sources

Besides clostridial, collagenases also come from various microbial and mammalian sources. Different sources have different cleavage sites, optimal conditions and inhibitor resistance. Selection should be based on the target tissue and process used, rather than comparing activity numbers alone.


6. Quality Control Plan

For finished collagenase, quality control should cover several dimensions: whether specific activity and unit definition are clear; whether off-target protease activity is present; whether endotoxin and host residue match the grade; whether batch consistency is acceptable; and whether the pH and temperature activity profile is stable. Writing these into internal and release standards ensures reproducibility of debridement or dissociation processes.


7. Selection and Product Plan


Collagenase selection and evaluation workflow.

 figure3. Collagenase selection and evaluation workflow

For procurement and R&D, evaluate collagenase across several dimensions: cleavage site and type combination (single type or I/II mix); whether specific activity and unit definition are comparable; levels of off-target protease and endotoxin; pH, temperature and cation compatibility; and batch consistency and supply stability. Bring the target tissue into real testing, judge with a repeatable dissociation or degradation curve, then decide on an off-the-shelf product or a custom route.


8. MATWINGS MALL Products and Custom Solutions

In its current tool-enzyme portfolio, MATWINGS MALL focuses on site-specific cleavage of recombinant proteins and glycan processing, such as recombinant Kex2, enterokinase, 3C protease, plus endoglycosidase H and endoglycosidase S for glycoprotein glycans, and proteinase K commonly used in nucleic acid extraction. These products serve "cleavage, impurity removal, lysis and dissociation" scenarios at different process nodes. For collagenase itself, the mall currently has no matching product on the shelf.

If your project has specific collagenase requirements, such as a mixed-type combination for a certain tissue, a specific pH window, lower off-target protease activity or higher batch consistency, MATWINGS MALL can support you from custom tool-enzyme development and protein engineering: redesign the enzyme molecule and perform directed evolution around the target tissue and process window; optimize activity and substrate preference; link computational design with wet-lab validation through an integrated R&D platform; then move through bioprocess development and scale-up to adapt to real samples and production. When a standard collagenase cannot meet the process on activity, specificity, batch consistency or compliance grade, a customized tool enzyme and protein engineering is a more system-matched route.


9. Frequently Asked Questions

Why can't a general protease degrade native collagen like collagenase?

Because native collagen is a dense superhelix of three α chains, and general proteases struggle to access the cleavage site, usually acting only on denatured or edge regions. Collagenase can enter and hydrolyze the triple helix under physiological conditions, with a specific cleavage site at X–Gly peptide bonds.


What is the optimal pH for collagenase?

Collagenase has an optimal pH of 6–8, with activity falling markedly outside this range. Debridement ointments and injectable formulations must maintain an appropriate pH to preserve activity and stability.


What is the difference between type I and type II collagenase?

Type I (e.g., AUX-I, ColG) and type II (e.g., AUX-II, ColH) are complementary; type II can work inside the triple helix. Together they degrade dense collagen more thoroughly, so clinical and islet-isolation scenarios favor a mixed type.


Which metal ions does collagenase activity require?

Collagenase is a metalloprotease; zinc at the active site drives catalysis and calcium stabilizes conformation and participates in substrate binding. Systems with chelators such as EDTA lower activity, so metal ions must be considered in selection and formulation.


Can the activity units of collagenase be compared across brands?

Not directly. Different assays correspond to different unit definitions; when substrate and readout differ, the numbers are not comparable. Selection should unify the substrate and assay, or verify directly with the target tissue using a real dissociation curve.


What if a standard collagenase fails on specificity or batch consistency?

When a commercial collagenase cannot meet the process on activity, specificity, batch consistency or compliance grade, turn to custom tool-enzyme development and protein engineering to rebuild the enzyme around the target tissue and process window, then move through process scale-up and production.


Conclusion

Collagenase is a protease that hydrolyzes native collagen in its triple-helical conformation under physiological conditions, cleaving mainly at X–Gly peptide bonds, dependent on zinc for catalysis and calcium for stability, with an optimal pH of 6–8. Clinically it is used for enzymatic debridement, Dupuytren's contracture and Peyronie's disease; in bioprocessing, for islet isolation and tissue dissociation. The main risk in industrial selection is not a weak enzyme but relying on activity numbers alone while ignoring cleavage site, metal dependence and batch drift. Using specific activity, cleavage site, off-target protease, endotoxin, batch consistency and pH window as the evaluation baseline, and bringing the target tissue into real testing, ensures correct and stable use. When a standard collagenase cannot meet process requirements, a customized tool enzyme and protein engineering is the more system-matched route.

Scan to join community

Scan to join community